新冠感染近期多发，线上线下药物热卖

Group 1 - The core viewpoint indicates a resurgence of COVID-19 cases in China, with a notable increase in positive rates among emergency and hospitalized patients, leading to a surge in demand for related medications [1][2] - The COVID-19 positive rate in emergency visits rose from 7.5% to 16.2%, and in hospitalized cases from 3.3% to 6.3% during the monitoring period from March 31 to May 4 [1] - The demand for COVID-19 medications has significantly increased, with online searches for related drugs on platforms like Meituan doubling in recent days, particularly in cities like Guangzhou and Shenzhen [3][6] Group 2 - Sales of certain anti-fever and cold medications have increased by 2 to 5 times year-on-year, indicating a heightened consumer interest in these products [6][7] - Specific products, such as Baiyunshan Banlangen, have become popular for their multifunctional benefits in treating COVID-19 and throat symptoms, reflecting a shift in consumer preferences towards effective home remedies [6][7] - Pharmacies report that the supply of various medications is sufficient, and consumers are advised to purchase as needed rather than stockpiling [6][7]